Moderna Inc. shares sank after new data showed the efficacy of its RSV shot fell sharply in the second year and was lower than that of rival vaccines.
Moderna RSV Vaccine Efficacy Sinks Over Time, CDC Documents ShowShale Executives See Takeovers Squeezing US Oil ProductionUS New-Home Sales Slump to Slowest Pace Since NovemberBlackstone Mulls Options for $5 Billion ConsultancyNY’s MTA Defers Second Avenue Subway Extension After Toll PauseMicron’s 65% Surge Puts Lofty AI Expectations Front And CenterBoston-Area Christian College to Close After Financial StrugglesYounger investors more likely to drop advisers, embrace DIY investing4 of the...
9%, Raising Bar for July CutKen Griffin Makes Largest Gift in Chicago Since Departing for MiamiBoeing-Lockheed Rocket Venture Swaps Payloads for September LaunchMcDonald’s Says Plant-Based Test in Two Key US Cities FailedAres’s Arougheti Sees More Deals as PE Investors Clamor for CashGates’ Climate VC Firm Turns Sights to the Developing WorldVolvo EV Deliveries to the US Delayed by Higher Tariffs on ChinaCiti Asks Staffers Not to Engage Protesters Swarming New York HQBronny James’ Agent Focused...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US FDA approves Moderna's RSV vaccine, its second marketed productExplore stories from Atlantic Canada.
Read more »
US FDA approves Moderna's RSV vaccine, its second marketed productExplore stories from Atlantic Canada.
Read more »
Moderna’s RSV Shot Wins FDA Approval for Use in Older AdultsModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech a second product as it seeks to move beyond its reliance on the fading Covid-19 market.
Read more »
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine dataModerna revealed its combination flu/COVID vaccine performed better than the two shots independently.
Read more »
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-upExplore stories from Atlantic Canada.
Read more »
US nears deal to fund Moderna's bird flu vaccine trial, FT reportsExplore stories from Atlantic Canada.
Read more »